A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
for Lipidemia
20 locations incl. Sun City West
Sponsor: NewAmsterdam Pharma
Sex: All·Age: 18+
Code: NCT07219602·Phase 3·Recruiting·Listed Oct 2025